Tuesday, November 25, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

FIGS Shares Decline After Oppenheimer Downgrade

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Finance_ Trading ratings today (2)
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

FIGS shares experienced a decline in trading following a downgrade by Oppenheimer on March 8, 2024. The stock was shifted from an “outperform” rating to a “market perform” rating, with the removal of a $9 price target. As a result, FIGS Inc. saw a 7.5% drop in stock value during early trading on Monday.

FIGS Stock Shows Modest Increase on March 8, 2024, Near 52-Week Low and Below 200-Day Moving Average

FIGS stock had a mixed performance on March 8, 2024, as it traded near the bottom of its 52-week range and below its 200-day simple moving average. The price of FIGS shares increased by $0.00 since the market last closed, representing a modest 0.09% rise. The stock opened at $5.19 on March 8, which was $0.17 lower than its previous close. This lower opening price may have been a result of market factors or investor sentiment. FIGS, a company that specializes in medical apparel, has had a volatile stock performance in recent months. Despite trading near the bottom of its 52-week range, the stock has shown some resilience with a slight increase on March 8. Investors may be keeping a close eye on FIGS stock to see if it can maintain its momentum and potentially move back towards its 200-day simple moving average. The performance of FIGS stock on March 8 may be an indication of how the stock will fare in the coming days and weeks. Investors should conduct their own research and analysis before making any investment decisions. Stock prices can be influenced by a variety of factors, and past performance is not always indicative of future results.

FIGS Inc. (FIGS) Reports Strong Financial Performance with Revenue Reaching $545.65 Million

On March 8, 2024, FIGS Inc. (FIGS) showed strong financial performance with total revenue reaching $545.65 million over the past year and $144.92 million in the fourth quarter. Net income for FIGS was reported at $22.64 million over the past year and $10.00 million in the fourth quarter. Earnings per share (EPS) for FIGS stood at $0.12 over the past year and $0.05 in the fourth quarter. Overall, FIGS demonstrated solid financial performance on March 8, 2024, with steady revenue growth, improved net income, and increasing earnings per share. Investors may view these positive financial indicators as a sign of a healthy and growing company, potentially leading to an increase in the stock price. It will be interesting to see how FIGS continues to perform in the future and whether it can sustain its growth momentum.

Tags: FIGS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Investment (2)

Truist Securities Analyst Maintains Hold Rating on Vornado Realty with Revised Price Target

Technology Artificial intelligence Markets and money

Baidus Stock Soars with Launch of Chinas First 247 Robotaxi Service

Investings on laptops and finances

The Power of Investing A Case Study with SP Global

Recommended

New Jersey Stock

A Dividend Powerhouse: New Jersey Resources Celebrates Three Decades of Payout Growth

2 months ago
Kimberly-Clark Stock

Kimberly-Clark Shares Plunge to Multi-Month Low Following Critical Analyst Report

1 month ago
Cytokinetics Stock

Cytokinetics Nears Pivotal FDA Decision on Heart Drug Candidate

3 months ago
Finance_Banking (2)

Barclays Analyst Upgrades Price Target for Honeywell International

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Micron’s Unprecedented Demand Signals Major Upside for Shares

Dow Jones Defies Nvidia’s Slide as Rate Cut Hopes Fuel Rally

Ballard Power Shares Plunge Amidst Sector Uncertainty

Super Micro Computer Faces Institutional Exodus Amid Earnings Disappointment

Cintas Shares Face Divergent Analyst Views Amid Strong Performance

Applovin Stock: Insider Selling Casts Shadow on Stellar Rally

Trending

Ethereum Stock
Analysis

Ethereum Gains Momentum as Institutional Investors Return

by Robert Sasse
November 25, 2025
0

After facing a period characterized by extreme fear, capital outflows, and general uncertainty, Ethereum is demonstrating renewed...

PacWest Stock

PacWest Shares Continue Their Steep Decline Amid Sector Concerns

November 25, 2025
Vulcan Energy Stock

Vulcan Energy Shares Find Their Footing After Recent Setbacks

November 25, 2025
Micron Stock

Micron’s Unprecedented Demand Signals Major Upside for Shares

November 25, 2025
Dow Jones Stock

Dow Jones Defies Nvidia’s Slide as Rate Cut Hopes Fuel Rally

November 25, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Ethereum Gains Momentum as Institutional Investors Return
  • PacWest Shares Continue Their Steep Decline Amid Sector Concerns
  • Vulcan Energy Shares Find Their Footing After Recent Setbacks

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com